$3.42
-0.22-6.04%
At close: -
$3.40
-0.02-0.55%
After Hours: 7:59 PM EDT
Comments
Loading...
ImmunityBio (NASDAQ:IBRX) Stock, Earnings Estimates, EPS, And Revenue
ImmunityBio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 18
EPS Estimate
$-0.260
Quarterly Revenue Estimate
$8.74M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$7.33M
Analyze the earnings history of ImmunityBio using advanced sorting and filters.
Data brought to you by Benzinga APIs
ImmunityBio (IBRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.14 | $-0.17 | 17.6 % |
| Q2 | 2024-08-12 | $-0.20 | $-0.17 | -17.6 % |
| Q1 | 2024-05-09 | $-0.20 | $-0.16 | -25.0 % |
| Q4 | 2024-03-19 | $-0.38 | $-0.18 | -111.1 % |
ImmunityBio (IBRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $6.11M | $4.36M | 40.1 % |
| Q2 | 2024-08-12 | $1.05M | $2.52M | -58.5 % |
| Q1 | 2024-05-09 | $40.00K | $20.00K | 100.0 % |
| Q4 | 2024-03-19 | $139.00K | $20.00K | 595.0 % |
FAQ
When is ImmunityBio (NASDAQ:IBRX) reporting earnings?
ImmunityBio (IBRX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for ImmunityBio (NASDAQ:IBRX)?
The Actual EPS was $-0.14, which beat the estimate of $-0.17.
What were ImmunityBio’s (NASDAQ:IBRX) revenues?
The Actual Revenue was $6.1M, which beat the estimate of $4.4M.
Browse earnings estimates, EPS, and revenue on all stocks.